English
简体中文
Total: £ 56.28
Published Date: 2025-08-08 | Pages: 92 | Tables: 96 | Medical Care
The global LFA-based Cardiac Marker market size was US$ 3839 million in 2024 and is forecast to a readjusted size of US$ 5853 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
LFA-based Cardiac Marker is a cardiac marker test based on lateral flow chromatography technology. Lateral flow chromatography technology is a detection method based on the principle of paper chromatography. It is widely used in the detection of disease biomarkers, especially in line with the World Health Organization's REASSURED principle in clinical testing, that is, reasonable cost, high sensitivity, strong specificity, convenient operation, fast and stable, no need for special equipment, easy promotion, real-time feedback, easy sampling, and environmentally friendly. Cardiac markers refer to proteins or enzymes that are released into the peripheral blood and detected during the course of heart disease. They can reflect changes in the structure or function of the heart. Cardiac marker detection based on lateral flow chromatography technology uses the advantages of lateral flow chromatography technology to quickly, accurately and conveniently detect cardiac markers to meet the clinical needs for immediate detection of heart disease.
Market Drivers
Rising Prevalence of Cardiovascular Diseases:
The prevalence of cardiovascular diseases is increasing globally, especially in low- and middle-income countries. This has led to an increase in demand for cardiac marker testing, as cardiac marker testing plays an important role in early diagnosis, risk assessment, and treatment monitoring of heart disease.
Technological Advances and Cost Reductions:
With the advancement of science and technology, the sensitivity and specificity of lateral flow chromatography technology has continued to improve, while the cost of testing has gradually decreased. This has made cardiac marker testing based on lateral flow chromatography technology more popular and acceptable, further driving the development of the market.
Growing Demand for Home Testing:
Home testing (also known as self-testing) allows users to test self-collected samples and obtain results without the assistance of trained medical professionals. This testing method plays an important role in cardiovascular diseases and infectious diseases. With the improvement of consumers' health awareness and the popularity of home testing products, the demand for cardiac marker home testing products based on lateral flow chromatography technology is also increasing.
Support from policies and regulations:
The policy support of governments for medical health and technological innovation has provided a good policy environment for the development of the cardiac marker testing market based on lateral flow chromatography technology. For example, the government may introduce relevant policies to encourage innovation, reduce testing costs, and improve testing accuracy, thereby promoting the development of the market.
Population aging and increased medical needs:
As the global population ages, the elderly population's demand for medical and health services continues to increase. Heart disease is one of the common chronic diseases among the elderly, so the application prospects of cardiac marker detection based on lateral flow chromatography technology in the elderly population are broad.
In summary, the development of the cardiac marker detection market based on lateral flow chromatography technology is driven by a variety of factors, including the increase in the prevalence of cardiovascular diseases, technological advances and cost reductions, the growth of home testing needs, policy and regulatory support, and the aging population and increased medical needs. These factors have jointly promoted the rapid development and widespread application of the market.
The global LFA-based Cardiac Marker market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Roche
Abbott
Siemens
Danaher
Bio-Rad Laboratories
BioMérieux
Thermo Fisher
Ortho Clinical Diagnostics
LSI Medience Corporation
Randox laboratories
Wondfo Biotech
By Type: (Dominant Segment vs High-Margin Innovation)
Troponin
CK-MB
Myoglobin
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Laboratory Testing
Point-of-care Testing
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Roche in Europe)
- Emerging Product Trends: Troponin adoption vs. CK-MB premiumization
- Demand-Side Dynamics: Laboratory Testing growth in China vs. Point-of-care Testing potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of LFA-based Cardiac Marker market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., CK-MB in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Point-of-care Testing in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the LFA-based Cardiac Marker value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Troponin
1.2.3 CK-MB
1.2.4 Myoglobin
1.2.5 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Laboratory Testing
1.3.3 Point-of-care Testing
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global LFA-based Cardiac Marker Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global LFA-based Cardiac Marker Revenue Market Share by Region (2020-2025)
2.4 Global LFA-based Cardiac Marker Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America LFA-based Cardiac Marker Market Size and Prospective (2020-2031)
2.5.2 Europe LFA-based Cardiac Marker Market Size and Prospective (2020-2031)
2.5.3 China LFA-based Cardiac Marker Market Size and Prospective (2020-2031)
2.5.4 Japan LFA-based Cardiac Marker Market Size and Prospective (2020-2031)
2.5.5 Southeast Asia LFA-based Cardiac Marker Market Size and Prospective (2020-2031)
2.5.6 India LFA-based Cardiac Marker Market Size and Prospective (2020-2031)
2.5.7 Central & South America LFA-based Cardiac Marker Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global LFA-based Cardiac Marker Historic Market Size by Type (2020-2025)
3.2 Global LFA-based Cardiac Marker Forecasted Market Size by Type (2026-2031)
3.3 Different Types LFA-based Cardiac Marker Representative Players
4 Breakdown Data by Application
4.1 Global LFA-based Cardiac Marker Historic Market Size by Application (2020-2025)
4.2 Global LFA-based Cardiac Marker Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in LFA-based Cardiac Marker Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top LFA-based Cardiac Marker Players by Revenue (2020-2025)
5.1.2 Global LFA-based Cardiac Marker Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by LFA-based Cardiac Marker Revenue
5.4 Global LFA-based Cardiac Marker Market Concentration Analysis
5.4.1 Global LFA-based Cardiac Marker Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by LFA-based Cardiac Marker Revenue in 2024
5.5 Global Key Players of LFA-based Cardiac Marker Head office and Area Served
5.6 Global Key Players of LFA-based Cardiac Marker, Product and Application
5.7 Global Key Players of LFA-based Cardiac Marker, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America LFA-based Cardiac Marker Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America LFA-based Cardiac Marker Market Size by Type (2020-2025)
6.1.2.2 North America LFA-based Cardiac Marker Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America LFA-based Cardiac Marker Market Size by Application (2020-2025)
6.1.3.2 North America LFA-based Cardiac Marker Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe LFA-based Cardiac Marker Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe LFA-based Cardiac Marker Market Size by Type (2020-2025)
6.2.2.2 Europe LFA-based Cardiac Marker Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe LFA-based Cardiac Marker Market Size by Application (2020-2025)
6.2.3.2 Europe LFA-based Cardiac Marker Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China LFA-based Cardiac Marker Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China LFA-based Cardiac Marker Market Size by Type (2020-2025)
6.3.2.2 China LFA-based Cardiac Marker Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China LFA-based Cardiac Marker Market Size by Application (2020-2025)
6.3.3.2 China LFA-based Cardiac Marker Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan LFA-based Cardiac Marker Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan LFA-based Cardiac Marker Market Size by Type (2020-2025)
6.4.2.2 Japan LFA-based Cardiac Marker Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan LFA-based Cardiac Marker Market Size by Application (2020-2025)
6.4.3.2 Japan LFA-based Cardiac Marker Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 Southeast Asia Market: Players, Segments and Downstream
6.5.1 Southeast Asia LFA-based Cardiac Marker Revenue by Company (2020-2025)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia LFA-based Cardiac Marker Market Size by Type (2020-2025)
6.5.2.2 Southeast Asia LFA-based Cardiac Marker Market Share by Type (2020-2025)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia LFA-based Cardiac Marker Market Size by Application (2020-2025)
6.5.3.2 Southeast Asia LFA-based Cardiac Marker Market Share by Application (2020-2025)
6.5.4 Southeast Asia Market Trend and Opportunities
6.6 India Market: Players, Segments and Downstream
6.6.1 India LFA-based Cardiac Marker Revenue by Company (2020-2025)
6.6.2 India Market Size by Type
6.6.2.1 India LFA-based Cardiac Marker Market Size by Type (2020-2025)
6.6.2.2 India LFA-based Cardiac Marker Market Share by Type (2020-2025)
6.6.3 India Market Size by Application
6.6.3.1 India LFA-based Cardiac Marker Market Size by Application (2020-2025)
6.6.3.2 India LFA-based Cardiac Marker Market Share by Application (2020-2025)
6.6.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 Roche
7.1.1 Roche Company Details
7.1.2 Roche Business Overview
7.1.3 Roche LFA-based Cardiac Marker Introduction
7.1.4 Roche Revenue in LFA-based Cardiac Marker Business (2020-2025)
7.1.5 Roche Recent Development
7.2 Abbott
7.2.1 Abbott Company Details
7.2.2 Abbott Business Overview
7.2.3 Abbott LFA-based Cardiac Marker Introduction
7.2.4 Abbott Revenue in LFA-based Cardiac Marker Business (2020-2025)
7.2.5 Abbott Recent Development
7.3 Siemens
7.3.1 Siemens Company Details
7.3.2 Siemens Business Overview
7.3.3 Siemens LFA-based Cardiac Marker Introduction
7.3.4 Siemens Revenue in LFA-based Cardiac Marker Business (2020-2025)
7.3.5 Siemens Recent Development
7.4 Danaher
7.4.1 Danaher Company Details
7.4.2 Danaher Business Overview
7.4.3 Danaher LFA-based Cardiac Marker Introduction
7.4.4 Danaher Revenue in LFA-based Cardiac Marker Business (2020-2025)
7.4.5 Danaher Recent Development
7.5 Bio-Rad Laboratories
7.5.1 Bio-Rad Laboratories Company Details
7.5.2 Bio-Rad Laboratories Business Overview
7.5.3 Bio-Rad Laboratories LFA-based Cardiac Marker Introduction
7.5.4 Bio-Rad Laboratories Revenue in LFA-based Cardiac Marker Business (2020-2025)
7.5.5 Bio-Rad Laboratories Recent Development
7.6 BioMérieux
7.6.1 BioMérieux Company Details
7.6.2 BioMérieux Business Overview
7.6.3 BioMérieux LFA-based Cardiac Marker Introduction
7.6.4 BioMérieux Revenue in LFA-based Cardiac Marker Business (2020-2025)
7.6.5 BioMérieux Recent Development
7.7 Thermo Fisher
7.7.1 Thermo Fisher Company Details
7.7.2 Thermo Fisher Business Overview
7.7.3 Thermo Fisher LFA-based Cardiac Marker Introduction
7.7.4 Thermo Fisher Revenue in LFA-based Cardiac Marker Business (2020-2025)
7.7.5 Thermo Fisher Recent Development
7.8 Ortho Clinical Diagnostics
7.8.1 Ortho Clinical Diagnostics Company Details
7.8.2 Ortho Clinical Diagnostics Business Overview
7.8.3 Ortho Clinical Diagnostics LFA-based Cardiac Marker Introduction
7.8.4 Ortho Clinical Diagnostics Revenue in LFA-based Cardiac Marker Business (2020-2025)
7.8.5 Ortho Clinical Diagnostics Recent Development
7.9 LSI Medience Corporation
7.9.1 LSI Medience Corporation Company Details
7.9.2 LSI Medience Corporation Business Overview
7.9.3 LSI Medience Corporation LFA-based Cardiac Marker Introduction
7.9.4 LSI Medience Corporation Revenue in LFA-based Cardiac Marker Business (2020-2025)
7.9.5 LSI Medience Corporation Recent Development
7.10 Randox laboratories
7.10.1 Randox laboratories Company Details
7.10.2 Randox laboratories Business Overview
7.10.3 Randox laboratories LFA-based Cardiac Marker Introduction
7.10.4 Randox laboratories Revenue in LFA-based Cardiac Marker Business (2020-2025)
7.10.5 Randox laboratories Recent Development
7.11 Wondfo Biotech
7.11.1 Wondfo Biotech Company Details
7.11.2 Wondfo Biotech Business Overview
7.11.3 Wondfo Biotech LFA-based Cardiac Marker Introduction
7.11.4 Wondfo Biotech Revenue in LFA-based Cardiac Marker Business (2020-2025)
7.11.5 Wondfo Biotech Recent Development
8 LFA-based Cardiac Marker Market Dynamics
8.1 LFA-based Cardiac Marker Industry Trends
8.2 LFA-based Cardiac Marker Market Drivers
8.3 LFA-based Cardiac Marker Market Challenges
8.4 LFA-based Cardiac Marker Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global LFA-based Cardiac Marker Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global LFA-based Cardiac Marker Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market LFA-based Cardiac Marker Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global LFA-based Cardiac Marker Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global LFA-based Cardiac Marker Revenue Share by Region (2020-2025)
Table 6. Global LFA-based Cardiac Marker Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global LFA-based Cardiac Marker Revenue Share Forecast by Region (2026-2031)
Table 8. Global LFA-based Cardiac Marker Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global LFA-based Cardiac Marker Revenue Market Share by Type (2020-2025)
Table 10. Global LFA-based Cardiac Marker Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global LFA-based Cardiac Marker Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global LFA-based Cardiac Marker Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global LFA-based Cardiac Marker Revenue Market Share by Application (2020-2025)
Table 15. Global LFA-based Cardiac Marker Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global LFA-based Cardiac Marker Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in LFA-based Cardiac Marker Application
Table 18. Global LFA-based Cardiac Marker Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global LFA-based Cardiac Marker Market Share by Players (2020-2025)
Table 20. Global Top LFA-based Cardiac Marker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LFA-based Cardiac Marker as of 2024)
Table 21. Ranking of Global Top LFA-based Cardiac Marker Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by LFA-based Cardiac Marker Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of LFA-based Cardiac Marker, Headquarters and Area Served
Table 24. Global Key Players of LFA-based Cardiac Marker, Product and Application
Table 25. Global Key Players of LFA-based Cardiac Marker, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America LFA-based Cardiac Marker Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America LFA-based Cardiac Marker Revenue Market Share by Company (2020-2025)
Table 29. North America LFA-based Cardiac Marker Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America LFA-based Cardiac Marker Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe LFA-based Cardiac Marker Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe LFA-based Cardiac Marker Revenue Market Share by Company (2020-2025)
Table 33. Europe LFA-based Cardiac Marker Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe LFA-based Cardiac Marker Market Size by Application (2020-2025) & (US$ Million)
Table 35. China LFA-based Cardiac Marker Revenue by Company (2020-2025) & (US$ Million)
Table 36. China LFA-based Cardiac Marker Revenue Market Share by Company (2020-2025)
Table 37. China LFA-based Cardiac Marker Market Size by Type (2020-2025) & (US$ Million)
Table 38. China LFA-based Cardiac Marker Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan LFA-based Cardiac Marker Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan LFA-based Cardiac Marker Revenue Market Share by Company (2020-2025)
Table 41. Japan LFA-based Cardiac Marker Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan LFA-based Cardiac Marker Market Size by Application (2020-2025) & (US$ Million)
Table 43. Southeast Asia LFA-based Cardiac Marker Revenue by Company (2020-2025) & (US$ Million)
Table 44. Southeast Asia LFA-based Cardiac Marker Revenue Market Share by Company (2020-2025)
Table 45. Southeast Asia LFA-based Cardiac Marker Market Size by Type (2020-2025) & (US$ Million)
Table 46. Southeast Asia LFA-based Cardiac Marker Market Size by Application (2020-2025) & (US$ Million)
Table 47. India LFA-based Cardiac Marker Revenue by Company (2020-2025) & (US$ Million)
Table 48. India LFA-based Cardiac Marker Revenue Market Share by Company (2020-2025)
Table 49. India LFA-based Cardiac Marker Market Size by Type (2020-2025) & (US$ Million)
Table 50. India LFA-based Cardiac Marker Market Size by Application (2020-2025) & (US$ Million)
Table 51. Roche Company Details
Table 52. Roche Business Overview
Table 53. Roche LFA-based Cardiac Marker Product
Table 54. Roche Revenue in LFA-based Cardiac Marker Business (2020-2025) & (US$ Million)
Table 55. Roche Recent Development
Table 56. Abbott Company Details
Table 57. Abbott Business Overview
Table 58. Abbott LFA-based Cardiac Marker Product
Table 59. Abbott Revenue in LFA-based Cardiac Marker Business (2020-2025) & (US$ Million)
Table 60. Abbott Recent Development
Table 61. Siemens Company Details
Table 62. Siemens Business Overview
Table 63. Siemens LFA-based Cardiac Marker Product
Table 64. Siemens Revenue in LFA-based Cardiac Marker Business (2020-2025) & (US$ Million)
Table 65. Siemens Recent Development
Table 66. Danaher Company Details
Table 67. Danaher Business Overview
Table 68. Danaher LFA-based Cardiac Marker Product
Table 69. Danaher Revenue in LFA-based Cardiac Marker Business (2020-2025) & (US$ Million)
Table 70. Danaher Recent Development
Table 71. Bio-Rad Laboratories Company Details
Table 72. Bio-Rad Laboratories Business Overview
Table 73. Bio-Rad Laboratories LFA-based Cardiac Marker Product
Table 74. Bio-Rad Laboratories Revenue in LFA-based Cardiac Marker Business (2020-2025) & (US$ Million)
Table 75. Bio-Rad Laboratories Recent Development
Table 76. BioMérieux Company Details
Table 77. BioMérieux Business Overview
Table 78. BioMérieux LFA-based Cardiac Marker Product
Table 79. BioMérieux Revenue in LFA-based Cardiac Marker Business (2020-2025) & (US$ Million)
Table 80. BioMérieux Recent Development
Table 81. Thermo Fisher Company Details
Table 82. Thermo Fisher Business Overview
Table 83. Thermo Fisher LFA-based Cardiac Marker Product
Table 84. Thermo Fisher Revenue in LFA-based Cardiac Marker Business (2020-2025) & (US$ Million)
Table 85. Thermo Fisher Recent Development
Table 86. Ortho Clinical Diagnostics Company Details
Table 87. Ortho Clinical Diagnostics Business Overview
Table 88. Ortho Clinical Diagnostics LFA-based Cardiac Marker Product
Table 89. Ortho Clinical Diagnostics Revenue in LFA-based Cardiac Marker Business (2020-2025) & (US$ Million)
Table 90. Ortho Clinical Diagnostics Recent Development
Table 91. LSI Medience Corporation Company Details
Table 92. LSI Medience Corporation Business Overview
Table 93. LSI Medience Corporation LFA-based Cardiac Marker Product
Table 94. LSI Medience Corporation Revenue in LFA-based Cardiac Marker Business (2020-2025) & (US$ Million)
Table 95. LSI Medience Corporation Recent Development
Table 96. Randox laboratories Company Details
Table 97. Randox laboratories Business Overview
Table 98. Randox laboratories LFA-based Cardiac Marker Product
Table 99. Randox laboratories Revenue in LFA-based Cardiac Marker Business (2020-2025) & (US$ Million)
Table 100. Randox laboratories Recent Development
Table 101. Wondfo Biotech Company Details
Table 102. Wondfo Biotech Business Overview
Table 103. Wondfo Biotech LFA-based Cardiac Marker Product
Table 104. Wondfo Biotech Revenue in LFA-based Cardiac Marker Business (2020-2025) & (US$ Million)
Table 105. Wondfo Biotech Recent Development
Table 106. LFA-based Cardiac Marker Market Trends
Table 107. LFA-based Cardiac Marker Market Drivers
Table 108. LFA-based Cardiac Marker Market Challenges
Table 109. LFA-based Cardiac Marker Market Restraints
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. LFA-based Cardiac Marker Product Picture
Figure 2. Global LFA-based Cardiac Marker Market Share by Type: 2024 VS 2031
Figure 3. Troponin Features
Figure 4. CK-MB Features
Figure 5. Myoglobin Features
Figure 6. Others Features
Figure 7. Global LFA-based Cardiac Marker Market Share by Application: 2024 VS 2031
Figure 8. Laboratory Testing
Figure 9. Point-of-care Testing
Figure 10. LFA-based Cardiac Marker Report Years Considered
Figure 11. Global LFA-based Cardiac Marker Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global LFA-based Cardiac Marker Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global LFA-based Cardiac Marker Revenue Market Share by Region: 2020 VS 2024
Figure 14. North America LFA-based Cardiac Marker Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. Europe LFA-based Cardiac Marker Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. China LFA-based Cardiac Marker Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Japan LFA-based Cardiac Marker Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Southeast Asia LFA-based Cardiac Marker Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. India LFA-based Cardiac Marker Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Central & South America LFA-based Cardiac Marker Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Global LFA-based Cardiac Marker Market Share by Players in 2024
Figure 22. Global Top LFA-based Cardiac Marker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LFA-based Cardiac Marker as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by LFA-based Cardiac Marker Revenue in 2024
Figure 24. North America LFA-based Cardiac Marker Market Share by Type (2020-2025)
Figure 25. North America LFA-based Cardiac Marker Market Share by Application (2020-2025)
Figure 26. Europe LFA-based Cardiac Marker Market Share by Type (2020-2025)
Figure 27. Europe LFA-based Cardiac Marker Market Share by Application (2020-2025)
Figure 28. China LFA-based Cardiac Marker Market Share by Type (2020-2025)
Figure 29. China LFA-based Cardiac Marker Market Share by Application (2020-2025)
Figure 30. Japan LFA-based Cardiac Marker Market Share by Type (2020-2025)
Figure 31. Japan LFA-based Cardiac Marker Market Share by Application (2020-2025)
Figure 32. Southeast Asia LFA-based Cardiac Marker Market Share by Type (2020-2025)
Figure 33. Southeast Asia LFA-based Cardiac Marker Market Share by Application (2020-2025)
Figure 34. India LFA-based Cardiac Marker Market Share by Type (2020-2025)
Figure 35. India LFA-based Cardiac Marker Market Share by Application (2020-2025)
Figure 36. Roche Revenue Growth Rate in LFA-based Cardiac Marker Business (2020-2025)
Figure 37. Abbott Revenue Growth Rate in LFA-based Cardiac Marker Business (2020-2025)
Figure 38. Siemens Revenue Growth Rate in LFA-based Cardiac Marker Business (2020-2025)
Figure 39. Danaher Revenue Growth Rate in LFA-based Cardiac Marker Business (2020-2025)
Figure 40. Bio-Rad Laboratories Revenue Growth Rate in LFA-based Cardiac Marker Business (2020-2025)
Figure 41. BioMérieux Revenue Growth Rate in LFA-based Cardiac Marker Business (2020-2025)
Figure 42. Thermo Fisher Revenue Growth Rate in LFA-based Cardiac Marker Business (2020-2025)
Figure 43. Ortho Clinical Diagnostics Revenue Growth Rate in LFA-based Cardiac Marker Business (2020-2025)
Figure 44. LSI Medience Corporation Revenue Growth Rate in LFA-based Cardiac Marker Business (2020-2025)
Figure 45. Randox laboratories Revenue Growth Rate in LFA-based Cardiac Marker Business (2020-2025)
Figure 46. Wondfo Biotech Revenue Growth Rate in LFA-based Cardiac Marker Business (2020-2025)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
